At last count, Ann Bartlett's blog on the FDA and insulin pumps has clocked in at least 32 comments (one of which was mine). A majority of these comments pertain to the choice of basal/bolus insulin regimes employed to treat type 1 diabetes. I have written other blogs that discuss insulin preparations, pros and cons of different regimes, and rationales behind the different choices. I would like to discuss the three basal/bolus regimes currently recommended by diabetes teams throughout the world.
